BHVN vs. SPY
BHVN (Biohaven Pharmaceutical Holding Company Ltd.) is a stock, while SPY (State Street SPDR S&P 500 ETF) is S&P 500 fund tracking the S&P 500 Index. Over the past 3 years, BHVN returned -13.95%/yr vs 20.68%/yr for SPY. At a 0.35 correlation, their price movements are largely independent.
Performance
BHVN vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BHVN achieves a 30.91% return, which is significantly higher than SPY's 8.15% return.
BHVN
- 1D
- -4.65%
- 1M
- 56.40%
- YTD
- 30.91%
- 6M
- 40.76%
- 1Y
- 2.21%
- 3Y*
- -13.95%
- 5Y*
- —
- 10Y*
- —
SPY
- 1D
- -1.45%
- 1M
- -1.36%
- YTD
- 8.15%
- 6M
- 7.20%
- 1Y
- 23.59%
- 3Y*
- 20.68%
- 5Y*
- 13.05%
- 10Y*
- 15.53%
BHVN vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
BHVN Biohaven Pharmaceutical Holding Company Ltd. | 30.91% | -69.77% | -12.73% | 208.36% | 131.33% |
SPY State Street SPDR S&P 500 ETF | 8.15% | 17.72% | 24.89% | 26.18% | 2.66% |
Correlation
The correlation between BHVN and SPY is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Sep 23, 2022 | 0.35 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BHVN vs. SPY — Risk / Return Rank
BHVN
SPY
BHVN vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BHVN | SPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.88 | ||
| Sortino ratioReturn per unit of downside risk | -1.84 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.34 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | 0.04 | 2.67 | -2.63 |
| Martin ratioReturn relative to average drawdown | 0.06 | 11.92 | -11.85 |
Loading charts...
Drawdowns
BHVN vs. SPY - Drawdown Comparison
The maximum BHVN drawdown since its inception was -86.96%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for BHVN and SPY.
Loading charts...
Drawdown Indicators
| BHVN | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.96% | -55.19% | -31.77% |
Max Drawdown (1Y)Largest decline over 1 year | -56.99% | -8.88% | -48.11% |
Max Drawdown (3Y)Largest decline over 3 years | -86.96% | -18.76% | -68.20% |
Max Drawdown (5Y)Largest decline over 5 years | — | -24.50% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.72% | — |
Current DrawdownCurrent decline from peak | -75.26% | -3.17% | -72.09% |
Average DrawdownAverage peak-to-trough decline | -39.00% | -9.04% | -29.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.23% | 1.98% | +32.25% |
Volatility
BHVN vs. SPY - Volatility Comparison
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) has a higher volatility of 30.69% compared to State Street SPDR S&P 500 ETF (SPY) at 4.87%. This indicates that BHVN's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BHVN | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.69% | 4.87% | +25.82% |
Volatility (6M)Calculated over the trailing 6-month period | 57.97% | 9.85% | +48.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.45% | 12.50% | +79.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 84.49% | 17.15% | +67.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.49% | 17.95% | +66.54% |
Dividends
BHVN vs. SPY - Dividend Comparison
BHVN has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.03%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BHVN Biohaven Pharmaceutical Holding Company Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 1.03% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
BHVN and SPY have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BHVN has higher volatility (30.69%) compared to SPY (4.87%). In terms of maximum drawdown, BHVN dropped -86.96% vs SPY's -55.19%.
SPY currently has the higher Sharpe Ratio (1.90 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BHVN and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer